Given these results and previous reports that eIF2α phosphorylation is upregulated in the neoplastic cells of melanoma, colon cancer, Hodgkin’s lymphoma, and TNBC [37], PKR-mediated eIF2α phosphorylation can potentially serve as a marker for TNBC. This evidence concerns the gene EIF2A and melanoma.